601 related articles for article (PubMed ID: 1996624)
1. Evidence against important catecholamine compensation for absent glucagon counterregulation.
De Feo P; Perriello G; Torlone E; Fanelli C; Ventura MM; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
Am J Physiol; 1991 Feb; 260(2 Pt 1):E203-12. PubMed ID: 1996624
[TBL] [Abstract][Full Text] [Related]
2. Contribution of cortisol to glucose counterregulation in humans.
De Feo P; Perriello G; Torlone E; Ventura MM; Fanelli C; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
Am J Physiol; 1989 Jul; 257(1 Pt 1):E35-42. PubMed ID: 2665516
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of a role for growth hormone in glucose counterregulation.
De Feo P; Perriello G; Torlone E; Ventura MM; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
Am J Physiol; 1989 Jun; 256(6 Pt 1):E835-43. PubMed ID: 2567576
[TBL] [Abstract][Full Text] [Related]
4. The pancreatic-adrenocortical-pituitary clamp technique for study of counterregulation in humans.
De Feo P; Perriello G; Ventura MM; Brunetti P; Santeusanio F; Gerich JE; Bolli GB
Am J Physiol; 1987 Apr; 252(4 Pt 1):E565-70. PubMed ID: 2882686
[TBL] [Abstract][Full Text] [Related]
5. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
[TBL] [Abstract][Full Text] [Related]
6. Catecholamines in prevention of hypoglycemia during exercise in humans.
Marker JC; Hirsch IB; Smith LJ; Parvin CA; Holloszy JO; Cryer PE
Am J Physiol; 1991 May; 260(5 Pt 1):E705-12. PubMed ID: 1674642
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.
Fanelli C; Calderone S; Epifano L; De Vincenzo A; Modarelli F; Pampanelli S; Perriello G; De Feo P; Brunetti P; Gerich JE
J Clin Invest; 1993 Oct; 92(4):1617-22. PubMed ID: 8408616
[TBL] [Abstract][Full Text] [Related]
8. Hypoinsulinemia is not critical to glucose recovery from hypoglycemia in humans.
Heller SR; Cryer PE
Am J Physiol; 1991 Jul; 261(1 Pt 1):E41-8. PubMed ID: 1858873
[TBL] [Abstract][Full Text] [Related]
9. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms.
Schwartz NS; Clutter WE; Shah SD; Cryer PE
J Clin Invest; 1987 Mar; 79(3):777-81. PubMed ID: 3546378
[TBL] [Abstract][Full Text] [Related]
10. Insulin and glucagon in prevention of hypoglycemia during exercise in humans.
Hirsch IB; Marker JC; Smith LJ; Spina RJ; Parvin CA; Holloszy JO; Cryer PE
Am J Physiol; 1991 May; 260(5 Pt 1):E695-704. PubMed ID: 2035626
[TBL] [Abstract][Full Text] [Related]
11. Attenuated glucose recovery from hypoglycemia in the elderly.
Marker JC; Cryer PE; Clutter WE
Diabetes; 1992 Jun; 41(6):671-8. PubMed ID: 1587394
[TBL] [Abstract][Full Text] [Related]
12. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
[TBL] [Abstract][Full Text] [Related]
13. Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting.
Boyle PJ; Shah SD; Cryer PE
Am J Physiol; 1989 May; 256(5 Pt 1):E651-61. PubMed ID: 2655471
[TBL] [Abstract][Full Text] [Related]
14. Comparison of glucose counterregulation during short-term and prolonged hypoglycemia in normal humans.
De Feo P; Perriello G; De Cosmo S; Ventura MM; Campbell PJ; Brunetti P; Gerich JE; Bolli GB
Diabetes; 1986 May; 35(5):563-9. PubMed ID: 2869997
[TBL] [Abstract][Full Text] [Related]
15. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
[TBL] [Abstract][Full Text] [Related]
16. Epinephrine's effect on metabolic rate is independent of changes in plasma insulin or glucagon.
Staten MA; Matthews DE; Cryer PE; Bier DM
Am J Physiol; 1989 Aug; 257(2 Pt 1):E185-92. PubMed ID: 2569829
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects.
Tse TF; Clutter WE; Shah SD; Miller JP; Cryer PE
J Clin Invest; 1983 Jul; 72(1):270-7. PubMed ID: 6409929
[TBL] [Abstract][Full Text] [Related]
18. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
19. Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise.
Tuttle KR; Marker JC; Dalsky GP; Schwartz NS; Shah SD; Clutter WE; Holloszy JO; Cryer PE
Am J Physiol; 1988 Jun; 254(6 Pt 1):E713-9. PubMed ID: 3287952
[TBL] [Abstract][Full Text] [Related]
20. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
